Aurinia Pharmaceuticals Inc Shares Outstanding 2014-2025 | AUPH

Aurinia Pharmaceuticals Inc shares outstanding from 2014 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Aurinia Pharmaceuticals Inc Annual Shares Outstanding (Millions of Shares)
2024	146
2023	143
2022	142
2021	129
2020	118
2019	93
2018	85
2017	77
2016	35
2015	32
2014	29
2013	6

Aurinia Pharmaceuticals Inc Quarterly Shares Outstanding (Millions of Shares)
2025-09-30	136
2025-06-30	138
2025-03-31	143
2024-12-31	146
2024-09-30	146
2024-06-30	144
2024-03-31	144
2023-12-31	143
2023-09-30	143
2023-06-30	143
2023-03-31	143
2022-12-31	142
2022-09-30	142
2022-06-30	142
2022-03-31	142
2021-12-31	129
2021-09-30	128
2021-06-30	128
2021-03-31	127
2020-12-31	118
2020-09-30	122
2020-06-30	113
2020-03-31	112
2019-12-31	93
2019-09-30	92
2019-06-30	92
2019-03-31	90
2018-12-31	85
2018-09-30	85
2018-06-30	84
2018-03-31	84
2017-12-31	77
2017-09-30	84
2017-06-30	83
2017-03-31	57
2016-12-31	35
2016-09-30	36
2016-06-30	33
2016-03-31	32
2015-12-31	32
2015-09-30	32
2015-06-30	32
2015-03-31	32
2014-12-31	29
2014-09-30	32
2014-06-30	31
2014-03-31	22
2013-12-31	13
2013-09-30	244
2013-06-30	199
2013-03-31	198

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$1.880B	$0.235B
Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.845B	31.38
Takeda Pharmaceutical (TAK)	Japan	$56.639B	11.12
Zoetis (ZTS)	United States	$55.849B	19.99
BeOne Medicines - (ONC)	Switzerland	$38.053B	201.74
Sandoz Group AG (SDZNY)	Switzerland	$34.527B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$34.382B	17.12
United Therapeutics (UTHR)	United States	$20.621B	18.15
Merck (MKKGY)	Germany	$18.598B	11.47
Shionogi (SGIOY)	Japan	$18.477B	14.29
Neurocrine Biosciences (NBIX)	United States	$13.752B	33.00
Ionis Pharmaceuticals (IONS)	United States	$13.522B	0.00
IPSEN (IPSEY)	France	$13.306B	0.00
Orion OYJ (ORINY)	Finland	$11.502B	32.86
Summit Therapeutics (SMMT)	United States	$10.680B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$10.525B	0.00
Eisai (ESAIY)		$8.400B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.149B	17.10
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.947B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.643B	22.05
Crinetics Pharmaceuticals (CRNX)	United States	$4.576B	0.00
Indivior Pharmaceuticals (INDV)	United States	$4.307B	17.58
Stevanato Group S.p.A (STVN)	Italy	$4.285B	23.98
Corcept Therapeutics (CORT)	United States	$4.035B	43.59
NewAmsterdam Pharma (NAMS)	Netherlands	$3.635B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.164B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.939B	9.38
Hypermarcas (HYPMY)	Brazil	$2.793B	19.17
Dyne Therapeutics (DYN)	United States	$2.364B	0.00
Soleno Therapeutics (SLNO)	United States	$2.126B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.109B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.081B	40.08
Ocular Therapeutix (OCUL)	United States	$1.898B	0.00
Harrow (HROW)	United States	$1.706B	104.68
Ardelyx (ARDX)	United States	$1.701B	0.00
Enliven Therapeutics (ELVN)	United States	$1.602B	0.00
Definium Therapeutics (DFTX)	United States	$1.601B	0.00
Oruka Therapeutics (ORKA)	United States	$1.521B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.483B	7.34
Amylyx Pharmaceuticals (AMLX)	United States	$1.427B	0.00
Relay Therapeutics (RLAY)	United States	$1.413B	0.00
BioCryst Pharmaceuticals (BCRX)	United States	$1.315B	78.00
Evotec AG (EVO)	Germany	$1.251B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.147B	0.00
Savara (SVRA)	United States	$1.050B	0.00
Theravance Biopharma (TBPH)	United States	$0.992B	41.66
Aktis Oncology (AKTS)	United States	$0.991B	0.00
Cronos Group (CRON)	Canada	$0.977B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.956B	0.00
Xencor (XNCR)	United States	$0.773B	0.00
Esperion Therapeutics (ESPR)	United States	$0.760B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.728B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.724B	17.11
Nektar Therapeutics (NKTR)	United States	$0.714B	0.00
Bioventus (BVS)	United States	$0.679B	13.91
Rigel Pharmaceuticals (RIGL)	United States	$0.603B	5.38
Altimmune (ALT)	United States	$0.555B	0.00
ProKidney (PROK)	United States	$0.520B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.503B	0.00
Lyell Immunopharma (LYEL)	United States	$0.481B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.479B	0.00
Organogenesis (ORGO)	United States	$0.471B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.471B	0.00
Aquestive Therapeutics (AQST)	United States	$0.468B	0.00
Siga Technologies (SIGA)	United States	$0.466B	6.38
Nature's Sunshine Products (NATR)	United States	$0.459B	27.33
Elite Pharmaceuticals (ELTP)	United States	$0.405B	0.00
USANA Health Sciences (USNA)	United States	$0.380B	10.62
Aclaris Therapeutics (ACRS)	United States	$0.367B	0.00
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Protara Therapeutics (TARA)	United States	$0.336B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.306B	0.00
Cybin (HELP)	Canada	$0.292B	0.00
Journey Medical (DERM)	United States	$0.278B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.275B	0.00
Relmada Therapeutics (RLMD)	United States	$0.264B	0.00
Larimar Therapeutics (LRMR)	United States	$0.254B	0.00
Avalo Therapeutics (AVTX)	United States	$0.243B	0.00
OmniAb (OABI)	United States	$0.238B	0.00
Profound Medical (PROF)	Canada	$0.229B	0.00
Heron Therapeutics (HRTX)	United States	$0.222B	0.00
MediWound (MDWD)	Israel	$0.221B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.214B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.210B	0.00
Context Therapeutics (CNTX)	United States	$0.208B	0.00
Minerva Neurosciences (NERV)	United States	$0.183B	0.00
Galectin Therapeutics (GALT)	United States	$0.182B	0.00
Surrozen (SRZN)	United States	$0.182B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.182B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
AleAnna (ANNA)	United States	$0.173B	0.00
VAXART, INC (VXRT)	United States	$0.150B	0.00
Century Therapeutics (IPSC)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.130B	0.00
Prelude Therapeutics (PRLD)	United States	$0.127B	0.00
Avita Medical (RCEL)	United States	$0.120B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.119B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.112B	0.00
Korro Bio (KRRO)	United States	$0.109B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.107B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.106B	0.00
Vivani Medical (VANI)	United States	$0.096B	0.00
Pyxis Oncology (PYXS)	United States	$0.096B	0.00
Cassava Sciences (SAVA)	United States	$0.091B	0.00
Champions Oncology (CSBR)	United States	$0.091B	38.41
Incannex Healthcare (IXHL)	Australia	$0.087B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
PolyPid (PYPD)	Israel	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.062B	0.00
Rafael Holdings (RFL)	United States	$0.061B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
Liminatus Pharma (LIMN)	United States	$0.055B	0.00
Dominari Holdings (DOMH)	United States	$0.055B	0.00
Fractyl Health (GUTS)	United States	$0.055B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.054B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.054B	44.88
Nutriband (NTRB)	United States	$0.053B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.052B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.050B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.050B	0.00
Lipocine (LPCN)	United States	$0.043B	0.00
ElectroCore (ECOR)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Lite Strategy (LITS)	United States	$0.035B	0.00
Plus Therapeutics (PSTV)	United States	$0.032B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.029B	0.00
SCYNEXIS (SCYX)	United States	$0.029B	0.00
Wellgistics Health (WGRX)	United States	$0.029B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.021B	0.00
Natural Alternatives (NAII)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Scienture Holdings (SCNX)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Klotho Neurosciences (KLTO)	United States	$0.016B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.015B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.015B	0.00
Vivos Therapeutics (VVOS)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Traws Pharma (TRAW)	United States	$0.014B	0.02
Inotiv (NOTV)	United States	$0.013B	0.00
Vyome Holdings (HIND)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Tempest Therapeutics (TPST)	United States	$0.011B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.005B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.005B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Indaptus Therapeutics (INDP)	United States	$0.003B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Jaguar Animal Health (JAGX)	United States	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.001B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00